Stem cell therapy (Corestem)

N/A

Report date: 2025/03/26 20:01:25

Base Information

Drug NameStem cell therapy (Corestem)

Drug Alias NameCS-20AT04

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derived

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsLupus Erythematosus, SystemicLupus Nephritis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesCorestemchemon Inc

China Registration ClassN/A

Develop Information

Active CompaniesCorestemchemon Inc

Inactive CompaniesN/A

Active IndicationsLupus Erythematosus, Systemic

Inactive IndicationsLupus Nephritis

Other Information

ATC CodeN/A